ETrade Capital Management’s Progressive PGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$1.54M Sell
16,304
-2,442
-13% -$219K 0.03% 269
2020
Q2
$1.5M Sell
18,746
-3,219
-15% -$251K 0.03% 256
2020
Q1
$1.62M Buy
21,965
+7,076
+48% +$545K 0.04% 220
2019
Q4
$1.08M Buy
14,889
+767
+5% +$55.3K 0.02% 348
2019
Q3
$1.09M Buy
14,122
+615
+5% +$48.4K 0.03% 325
2019
Q2
$1.08M Sell
13,507
-14,826
-52% -$1.15M 0.03% 329
2019
Q1
$2.04M Sell
28,333
-10,436
-27% -$715K 0.06% 201
2018
Q4
$2.34M Sell
38,769
-650
-2% -$43.2K 0.08% 151
2018
Q3
$2.8M Sell
39,419
-537
-1% -$34.5K 0.08% 141
2018
Q2
$2.36M Buy
39,956
+5,102
+15% +$312K 0.07% 159
2018
Q1
$2.12M Sell
34,854
-4,255
-11% -$243K 0.07% 170
2017
Q4
$2.2M Buy
39,109
+8,619
+28% +$446K 0.07% 167
2017
Q3
$1.48M Buy
30,490
+13,032
+75% +$610K 0.05% 216
2017
Q2
$770K Buy
+17,458
New +$725K 0.03% 364

Other funds holding PGR

ETrade Capital Management's PGR Position: Q3 2020 in Review

ETrade Capital Management reduced its Progressive (PGR) stake by 13% in Q3 2020, selling an estimated $219K and leaving 16,304 shares worth $1.54M. The position accounts for 0.03% of the portfolio, ranked #269.

ETrade Capital Management first reported a position in PGR in Q2 2017 and has held it in 14 quarters since. The position peaked at $2.8M in Q3 2018. 951 funds tracked by Wall St. Rank hold PGR as of Q3 2020.

  • ETrade Capital Management held 16,304 shares of Progressive worth $1.54M as of Q3 2020.
  • ETrade Capital Management sold 2,442 Progressive shares in Q3 2020, an estimated $219K.
  • Progressive made up 0.03% of ETrade Capital Management's portfolio in Q3 2020, its #269 holding.
  • ETrade Capital Management first reported a position in Progressive in Q2 2017 and has held it in 14 quarters since.
  • ETrade Capital Management's Progressive position peaked at $2.8M in Q3 2018.
  • 951 funds tracked by Wall St. Rank held Progressive as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.